NasdaqGS - Nasdaq Real Time Price USD

Omnicell, Inc. (OMCL)

Compare
42.79 +0.46 (+1.09%)
As of 3:40 PM EDT. Market Open.
Loading Chart for OMCL
DELL
  • Previous Close 42.33
  • Open 42.80
  • Bid 42.67 x 100
  • Ask 42.94 x 100
  • Day's Range 42.68 - 43.73
  • 52 Week Range 25.12 - 46.48
  • Volume 189,751
  • Avg. Volume 567,098
  • Market Cap (intraday) 1.968B
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) --
  • EPS (TTM) -0.45
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 44.50

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

www.omnicell.com

3,630

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OMCL

View More

Performance Overview: OMCL

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OMCL
13.71%
S&P 500
20.32%

1-Year Return

OMCL
6.12%
S&P 500
34.29%

3-Year Return

OMCL
72.26%
S&P 500
28.81%

5-Year Return

OMCL
41.47%
S&P 500
92.74%

Compare To: OMCL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OMCL

View More

Valuation Measures

Annual
As of 9/26/2024
  • Market Cap

    1.95B

  • Enterprise Value

    1.99B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.79

  • Price/Book (mrq)

    1.62

  • Enterprise Value/Revenue

    1.84

  • Enterprise Value/EBITDA

    36.24

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.92%

  • Return on Assets (ttm)

    -0.99%

  • Return on Equity (ttm)

    -1.75%

  • Revenue (ttm)

    1.08B

  • Net Income Avi to Common (ttm)

    -20.76M

  • Diluted EPS (ttm)

    -0.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    556.78M

  • Total Debt/Equity (mrq)

    51.17%

  • Levered Free Cash Flow (ttm)

    145.45M

Research Analysis: OMCL

View More

Company Insights: OMCL

Research Reports: OMCL

View More

People Also Watch